News
The EMA/HMA network strategy to 2025 supports the uptake computer modelling and simulation
On 8 December, the European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have published their final European medicines agencies network strategy to 2025 giving their strategic direction to work of the European Medicines Regulatory Network.
Towards Good Simulation Practice – An interview of Luca Emili and Prof. Marco Viceconti
During the 2020 Avicenna Day many experts from all over the world talked about the need for Good Simulation Practice, a term coined by the Avicenna Alliance taking inspiration from the Good Clinical Practice typical of the clinical world to bring similar rules to Modeling & Simulation applied to the Pharmaceutical and Medical Devices industries.
The Priorities of the Portuguese Presidency of the Council of the European Union of 2021
On 1 and 2 December, Portuguese Prime Minister António Costa presented to the EU institutions the Priorities of the Portuguese Presidency of the Council of the European Union of 2021.These priorities will shape the work of the Council of the EU directly for the next 6 months, and indirectly by setting up the stage for coming presidencies.
In silico techniques are mentioned in Pharmaceutical Strategy for Europe
On 25 November, the European Commission adopted its much-awaited Pharmaceutical strategy for Europe providing a comprehensive and ambitious action plan on pharmaceuticals.
EU Commission recognizes benefits of in silico medicine in its European Health Union proposals
The set of proposals for a European Health Union published by the European Commission on 11 November, represents one of the most ambitious policy package on health care issues and the role of the EMA and the ECDC.
The European Commission publishes set of proposals on European Health Union
On 11 November the European Commission published a set of proposals for the European Health Union.
